Get the Stockscreener App
0.49
28.99%
-0.20
Biotricity Inc stock is traded at $0.49, with a volume of 28,926.
It is down -28.99% in the last 24 hours and down -28.99% over the past month.
See More
Previous Close:
$0.69
Open:
$0.45
24h Volume:
28,926
Relative Volume:
18.45
Market Cap:
$N/A
Revenue:
$11.63M
Net Income/Loss:
$-14.58M
P/E Ratio:
-0.2798
EPS:
-1.751
Net Cash Flow:
$-7.41M
1W Performance:
-28.99%
1M Performance:
-28.99%
6M Performance:
-42.72%
1Y Performance:
-79.83%
1-Day Range:
$0.45
$0.49
1-Week Range:
$0.45
$0.49
52-Week Range:
$0.41
$0.7297
Biotricity Inc Stock (BTCY) Company Profile
Compare BTCY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.93 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.50 | 4.01B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2215 | 480.44M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.09 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.67 | 220.48M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.90 | 0 | 0 | 0 | 0 | 0.00 |
Biotricity Inc Stock (BTCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-22 | Initiated | Lake Street | Buy |
| Nov-23-21 | Initiated | H.C. Wainwright | Buy |
Biotricity Inc Stock (BTCY) Latest News
Biotricity, Inc. (OTC:BTCY) Q2 2026 Earnings Call Transcript - MSN
Contrasting Nemaura Medical (NASDAQ:NMRD) & Biotricity (NASDAQ:BTCY) - Defense World
Biotricity’s Earnings Call: Growth and Positive Outlook - The Globe and Mail
Biotricity Inc. Reports Revenue Growth Amid Financial Challenges - The Globe and Mail
Biotricity Inc (BTCY) Q2 2026 Earnings Call Highlights: Revenue Surge and Strategic Expansion By GuruFocus - Investing.com Canada
Biotricity Inc. (BTCY) Reports Q2 Loss, Lags Revenue Estimates - sharewise.com
Biotricity Inc (BTCY) Q2 2026 Earnings Call Highlights: Revenue Surge and Strategic Expansion - Yahoo Finance
Biotricity reports 19% revenue growth in Q2 fiscal 2026 By Investing.com - Investing.com Nigeria
Earnings call transcript: Biotricity Q2 2026 sees revenue rise 19% By Investing.com - Investing.com Canada
Transcript : Biotricity, Inc., Q2 2026 Earnings Call, Nov 14, 2025 - MarketScreener
Earnings call transcript: Biotricity Q2 2026 sees revenue rise 19% - Investing.com
Biotricity reports 19% revenue growth in Q2 fiscal 2026 - Investing.com
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026 - MarketScreener
Biotricity Strengthens Path to Scalable Profitability with - GlobeNewswire
BIOTRICITY INC. SEC 10-Q Report - TradingView
Biotricity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 - MarketScreener
Biotricity : strengthens path to scalable profitability for second quarter Fiscal 2026 with sustained margins & operational efficiency - MarketScreener
Biotricity (OTCMKTS:BTCY) versus Standard BioTools (NASDAQ:LAB) Financial Review - Defense World
Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th - MarketScreener
Biotricity (BTCY) Expected to Announce Quarterly Earnings on Thursday - Defense World
Total debt per share of Biotricity Inc. – OTC:BTCY - TradingView
Biotricity (NASDAQ:BTCY) Trading Up 3.2% – Here’s Why - Defense World
Slammed 34% Biotricity, Inc. (NASDAQ:BTCY) Screens Well Here But There Might Be A Catch - 富途牛牛
Biotricity Inc. Financial Disclosures & SEC Filings - TradingView
Comparing Biotricity (OTCMKTS:BTCY) and iRhythm Technologies (NASDAQ:IRTC) - Defense World
Head-To-Head Analysis: Mitesco (OTCMKTS:MITI) and Biotricity (OTCMKTS:BTCY) - Defense World
Biotricity (NASDAQ:BTCY) Trading 2.5% Higher – Still a Buy? - Defense World
H-CYTE (OTCMKTS:HCYTD) versus Biotricity (NASDAQ:BTCY) Financial Review - Defense World
Biotricity, B-Secur Augment Next-Generation Cardiac Monitoring Platform - Medical Product Outsourcing
Biotricity to Present its Disruptive Medical Technologies at the Benzinga Global Small Cap Conference on May 14 - FinancialContent
Reviewing Biotricity (OTCMKTS:BTCY) and P3 Health Partners (NASDAQ:PIII) - Defense World
Biotricity (BTCY) Expands Market Reach Through New Partnership - GuruFocus
Health-E Commerce® and Biotricity® Collaborate to Expand Remote Cardiac Monitoring with Bioheart® for Flexible Spending Account (FSA) and Health Savings Account (HSA) Users – Company AnnouncementFT.com - Financial Times
Health-E Commerce® and Biotricity® Collaborate to Expand Remote Cardiac Monitoring with Bioheart® for Flexible Spending Account (FSA) and Health Savings Account (HSA) Users - PR Newswire
Biotricity, B-Secur expand cardiac monitoring platform - TipRanks
Biotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring Platform - GlobeNewswire
FDA-Cleared Heart Monitoring Tech Now Available for Smartwatches: Biotricity, B-Secur Transform Wearables - Stock Titan
Biotricity reports Q1 EPS (3c) vs (49c) last year - MSN
Biotricity (OTCMKTS:BTCY) Shares Down 5.3% – Here’s Why - Defense World
Head to Head Survey: Biostage (OTCMKTS:BSTG) and Biotricity (NASDAQ:BTCY) - Defense World
Critical Survey: Retractable Technologies (NYSE:RVP) versus Biotricity (NASDAQ:BTCY) - Defense World
Are Medical Stocks Lagging Biotricity (BTCY) This Year? - NewsBreak: Local News & Alerts
Biotricity (BTCY) Upgraded to Buy: Here's Why - MSN
Biotricity expands intellectual property portfolio with 14 new patents - MSN
Biotricity Inc Stock (BTCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.78%
0.34%
Cap:
|
Volume (24h):